Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Sackler family, Purdue Pharma reach $7.4 billion settlement with 15 states over opioid crisis
The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement with a bipartisan coalition of 15 states for fueling the opioid crisis, New York Attorney General Letitia James announced Thursday.
Purdue & Sackler Family Agree $7.4B OxyContin Settlement
The Sackler family and Purdue Pharma have agreed to a $7.4 billion settlement to resolve federal claims brought by attorneys general from 15 states. Announced by New York Attorney General Letitia James,
Mass. could get more than $100 million in new OxyContin settlement with Purdue Pharma
The Sackler family and Purdue Pharma agreed to pay $7.4 billion to settle lawsuits over the toll of the powerful prescription painkiller. Massachusetts Attorney General Andrea Campbell said that the state could receive up to $108 million of the settlement money.
Purdue Pharma owners could pay $7.4 billion settlement over OxyContin toll
Members of the family who own OxyContin maker Purdue Pharma agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of OxyContin.
Purdue and Sackler family agree to $7.4bn national opioid settlement
Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running legal saga involving the pain medication Oxycontin and its role in fuelling the opioid epidemic in the country.
AG: Pa. part of $7.4B OxyContin settlement proposal with Purdue Pharma, Sackler family
Pennsylvania stands to receive up to $212 million paid out by the family and company behind the nationwide saturation of OxyContin as part of the latest legal settlement stemming from
Purdue Pharma, Sackler family owners agree to landmark $7.4B opioid settlement
The latest settlement is meant to address a drug addiction crisis that has led to over 700,000 opioid overdose deaths in the US over the past two decades.
Pennsylvania to get $212 million from opioids settlement with Purdue Pharma, Sackler family
Pennsylvania may receive up to $212 million over 15 years as part of a multi-state lawsuit settlement with Purdue Pharma and the Sackler family, its owners, for their roles in the opioid overdose crisis.
Purdue Pharma, Sackler family to pay $7.4 billion opioid settlement
Purdue Pharma, the manufacturers of OxyContin, and members of the family that own the company, will pay billions to victims of the opioid crisis, as well as state and local governments.
Sackler family and Purdue agree to pay Utah $57 million for opioid damages
Prescription opioid overdoses have killed thousands of Utahns. A new settlement puts a price tag on their lives and could bring "justice" to their families."
New York attorney general announces new Purdue Pharma opioid crisis settlement
New York Attorney General Letitia James announced Thursday a new $7.5 billion settlement with Purdue Pharmaceuticals and the Sackler Family for their role in the ongoing US opioid crisis with the
5d
on MSN
Sackler Family’s Net Worth: How Much Money They’re Worth Now
The individuals behind Purdue Pharma’s involvement in the U.S. opioid crisis reached a $7-billion settlement in January 2025.
5d
on MSN
Sackler family to pay $6.5 billion for their role in ‘fueling’ opioid epidemic which has killed hundreds of thousands
Sackler family, who owned pharmaceutical company Purdue Pharma, will no longer be in control of the company or permitted to sell opioids if the new settlement plan is approved ...
penncapital-star
5d
PA expected to receive over $200 million in settlement with OxyContin makers, if approved
Pennsylvania expects to receive $212 million over 15 years as part of a multi-state settlement with the Sackler family.
4d
OxyContin makers to pay up to $7.4B in new deal
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback